BackSino Biopharmaceutical Limited Overview

Sino Biopharmaceutical Limited Minority Interest

Track Sino Biopharmaceutical Limited's minority interest ($14B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$13.68B
↑ 10.26% YoYΔ $1.27B vs prior year quarter

Peer trimmed avg / median

Loading

Sino Biopharmaceutical Limited Minority Interest History

Loading

Sino Biopharmaceutical Limited vs. peers: Minority Interest Comparison

Loading

Sino Biopharmaceutical Limited Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sino Biopharmaceutical Limited (SBMFF) FAQ

Sino Biopharmaceutical Limited (SBMFF) currently reports a minority interest of $14B as of June 2026. That compares with $12B in the prior-year period — up 10.3% year over year. Use the charts on this page to explore Sino Biopharmaceutical Limited's minority interest history and peer comparisons.

Sino Biopharmaceutical Limited's minority interest increased from $12B to $14B — a 10.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sino Biopharmaceutical Limited reported $14B in minority interest as of June 2026. That compares with $12B in the prior-year period — up 10.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current minority interest of $14B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sino Biopharmaceutical Limited, and consider following SBMFF for alerts when major investors trade the stock.

Sino Biopharmaceutical Limited is classified in the Healthcare sector. On minority interest, it currently shows $14B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SBMFF with unrelated industries.